Actively Recruiting
Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-05-07
400
Participants Needed
1
Research Sites
778 weeks
Total Duration
On this page
Sponsors
N
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
U
University of Arizona
Collaborating Sponsor
AI-Summary
What this Trial Is About
Background: \- Coccidioidomycosis is caused by a fungus that grows in the southwest United States and parts of Mexico and South America. This disease is caused by breathing dust containing the fungus. It can lead to serious lung and breathing problems. Rarely, the fungus can infect other body parts. This is called disseminated coccidioidomycosis (DCM). If the fungus stays in the lungs for more than 6 months, it is called refractory coccidioidomycosis (RCM). People with DCM or RCM may have difficulty fighting off infection because of immune system problems. Researchers want to study the immune systems of people with DCM or RCM, to learn more about the disease and the best ways to treat it. They also want to learn more about the types of people that get DCM or RCM and about the fungus that causes it. Objectives: \- To learn more about DCM and RCM, the fungus that causes these diseases, and the people who get them. Eligibility: \- People over age 2 with DCM or RCM. Design: * Participants will be screened with a review of their medical records. * At the initial visit, participants will have: * Medical history and physical exam * Blood and urine tests. Some blood may be used for genetic testing. The samples will not include participants names. Participants will be notified only if the tests show something urgent about their DCM/RCM. Researchers think this sort of problem will be rare. * Questionnaire about their DCM/RCM * Sputum (mucus) collection. They will spit into a cup. * Participants will have 1 follow-up visit per year. They will have blood tests. They may have other procedures to treat their DCM/RCM.
CONDITIONS
Official Title
Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 2 years or older
- Medically stable if pediatric and acutely ill
- Positive Coccidioides antigen or culture-proven refractory pulmonary coccidioidomycosis lasting at least 6 months
- Positive Coccidioides antigen or culture-proven disseminated coccidioidomycosis outside the chest
- Agree to genetic testing
- Allow samples to be stored for future research
You will not qualify if you...
- HIV infection
- Taking more than 20 mg/day prednisone or active immunosuppressive therapy
- Any medical, psychiatric, social, occupational, or other condition that impairs ability to give informed consent or is a contraindication to participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
Research Team
D
Dawn E Shaw, R.N.
CONTACT
S
Steven M Holland, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here